Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
基本信息
- 批准号:8898981
- 负责人:
- 金额:$ 0.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AppearanceArthritisAryl Hydrocarbon ReceptorAutoimmune DiseasesBacteriaBacteroides fragilisC57BL/6 MouseCD4 Positive T LymphocytesCarbazolesCell Differentiation processCellsChemicalsCholineClostridiumColitisCollaborationsCommunitiesCompetenceComplementCrohn&aposs diseaseDevelopmentDietary ComponentDioxinsDiseaseDisease OutcomeEnvironmental ExposureEnvironmental PollutionEquilibriumEvaluationExcretory functionExposure toFatty LiverFatty acid glycerol estersGene Expression ProfileGenerationsGenesGerm-FreeHealthHelicobacterHepaticHepatotoxicityHomeostasisImmuneImmune responseImmune systemInflammatory Bowel DiseasesInflammatory ResponseInstructionInterleukin-10Interleukin-17Interleukin-6LeadLigandsLinkLiver diseasesMeasuresMetabolismMono-SMusOdorsPathway interactionsPlayPolysaccharidesPopulationProductionRegulationRegulatory T-LymphocyteRelative (related person)Research PersonnelResearch SupportRiversRoleSamplingSiteSkin CancerStudentsSyndromeSystemTestingTetrachlorodibenzodioxinTrainingTransforming Growth FactorsTranslational ResearchUp-Regulationaryl hydrocarbon receptor ligandbasecarbazolecholine deficient dietdesignfatty acid transportgenome sequencinginterestinterleukin-22membermicrobialmicrobiomemouse modelnon-alcoholic fatty liverpathogenpreventpromoterresearch studyresponsetranscriptomicstrimethylaminetrimethyloxamineurinary
项目摘要
PROJECT SUIVIMARY (See instructions):
Role of key microbial populations of the gut microbiome in formulating host response as a result of 2,3,7,8- tetrahlorodibenzo-p-dioxin (TCDD) exposure is only beginning to be studied. Evidence suggests that gut microbiome is intricately linked to the host response and is also impacted directly and indirectly by exposure to environmental contaminants. In this project two such interactions are proposed to be studied using C57BL/6 germ free, mono-associated, cocktail associated and traditionally raised mouse models. The first is related to Treg/Th17 immune regulatory system and its dysbiosis in response to dioxin exposure and the second is related to choline-trimethylamine (TMA) pathway and its modulation. Dysbiosis of Treg/Th17 system has a broad range of health effects due to its central role in the immune regulatory system. It may lead to autoimmune diseases such as arthritis, inflammatory bowel disease, and skin cancer. Recently, specific
members of the gut community, such as segmented filamentous bacteria (SFBs for which whole genome sequences are now available) and cluster IV and XlVa Clostridia, and Bacteroides fragilis have been implicated in regulating the Treg/Th17 system. The Treg/Th17 balance is also impacted by dioxin because AhR promotes the generation of Foxp3+ Treg and suppresses the differentiation to IL-17 producing ROR-yt Thi7.
Thus specific populations of the gut microbiome, the Treg/Th17 balance, and TCDD via its AhR system are interconnected. Its mis-regulation may lead to disease outcomes. Project 4 establishes these specific and opposing "mechanisms" of regulation in germ-free mice using SFBs, 6. fragilis, and cluster IV and XlVa Clostridia and studies the role of these gut microbial populations in making the host less or more susceptible
to health effects of dioxins. Evaluation of the transcriptome response of cluster IV and XlVa Clostridia and SFBs in response to TCDD, 2,3,4,7,9-PeCDF, and 2,3,7,8-TCDF exposure is also proposed. Project 4 also examines the effects of TCDD and related compounds on the metabolism of choline by the host and the gut microbiome, and the potential roles in the development of fatty liver and altering urinary
trimethylamine/trimethylamine-N-oxide (TMA/TMAO) ratios. The effects are being studied in collaboration with Projects 1 (Kaminski/Kaplan), 3 (Zacharewski), 5 (Zylstra), and 6 (Boyd) and Research Support Cores A and B. The results are disseminated to communities and researchers through the Community Engagement Core and Research Translation Core. Student projects are designed to be incorporated in the Training Core.
项目SuIVIMARY(请参阅说明):
肠道微生物组的关键微生物群在2,3,7,8-四氯二苯并-对二恶英(TCDD)暴露引起的宿主反应中的作用才刚刚开始研究。有证据表明,肠道微生物群与宿主的反应有着千丝万缕的联系,也直接或间接地受到环境污染物的影响。在这个项目中,建议使用无菌、单相关、鸡尾酒相关和传统饲养的小鼠模型来研究两种这样的相互作用。第一个与Treg/Th17免疫调节系统及其对二恶英暴露的生物失调有关,第二个与胆碱-三甲胺(TMA)途径及其调节有关。由于其在免疫调节系统中的核心作用,Treg/Th17系统的生物失调具有广泛的健康影响。它可能导致自身免疫性疾病,如关节炎、炎症性肠病和皮肤癌。最近,具体
肠道群落的成员,如节段性丝状细菌(现已获得其全基因组序列的SFB)、簇IV和XlVa梭状杆菌,以及脆弱类杆菌,都参与了Treg/Th17系统的调节。二恶英也影响Treg/Th17的平衡,因为AhR促进Foxp3+Treg的产生,并抑制向IL-17的分化,产生ROR-yt Thi7。
因此,肠道微生物组的特定种群、Treg/Th17平衡和TCDD通过其AhR系统相互关联。它的错误调控可能会导致疾病后果。项目4使用SFBS、6.脆弱菌、第IV簇和XlVa梭状芽胞杆菌在无菌小鼠中建立了这些特定的和相反的“调节机制”,并研究了这些肠道微生物种群在使宿主更少或更容易受到感染方面的作用
二恶英对健康的影响。此外,还提出了对簇IV和XlVa梭状芽孢杆菌和SFB对TCDD、2,3,4,7,9-PeCDF和2,3,7,8-TCDF暴露的转录组反应的评估。项目4还检查了TCDD和相关化合物对宿主和肠道微生物群胆碱代谢的影响,以及在脂肪肝和尿液改变中的潜在作用。
三甲胺/三甲胺-N-氧化物(TMA/TMAO)比率。正在与项目1(Kaminski/Kaplan)、项目3(Zacharewski)、项目5(Zylstra)和项目6(Boyd)以及研究支助核心A和B合作研究影响。结果通过社区参与核心和研究翻译核心传播给社区和研究人员。学生项目的设计是为了纳入培训核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SYED A. HASHSHAM其他文献
SYED A. HASHSHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SYED A. HASHSHAM', 18)}}的其他基金
Flexible Biochip for Highly Parallel Microbial Detection
用于高度并行微生物检测的灵活生物芯片
- 批准号:
6782568 - 财政年份:2003
- 资助金额:
$ 0.42万 - 项目类别:
Flexible Biochip for Highly Parallel Microbial Detection
用于高度并行微生物检测的灵活生物芯片
- 批准号:
6918525 - 财政年份:2003
- 资助金额:
$ 0.42万 - 项目类别:
Flexible Biochip for Highly Parallel Microbial Detection
用于高度并行微生物检测的灵活生物芯片
- 批准号:
6676435 - 财政年份:2003
- 资助金额:
$ 0.42万 - 项目类别:
Project 4 - Design Principles and Field-Deployable Models for Economical Remediation of Dioxin-Contaminated Sites
项目 4 - 二恶英污染场地经济修复的设计原则和可现场部署模型
- 批准号:
10353534 - 财政年份:1997
- 资助金额:
$ 0.42万 - 项目类别:
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
- 批准号:
8564237 - 财政年份:
- 资助金额:
$ 0.42万 - 项目类别:
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
- 批准号:
8829254 - 财政年份:
- 资助金额:
$ 0.42万 - 项目类别:
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
- 批准号:
9257387 - 财政年份:
- 资助金额:
$ 0.42万 - 项目类别:
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
- 批准号:
9058531 - 财政年份:
- 资助金额:
$ 0.42万 - 项目类别:
Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure
项目 4:肠道微生物组 - 宿主对 TCDD 暴露的反应
- 批准号:
8695354 - 财政年份:
- 资助金额:
$ 0.42万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别: